Features of Potentially Predictive Biomarkers of Chemotherapeutic Efficacy in Small Cell Lung Cancer

INTRODUCTION: One-size-fits-all chemotherapy does not improve survival in patients with small cell lung cancer (SCLC). Excision repair cross complementing group 1 (ERCC1), ribonucleotide reductase 1 (RRM1), thymidylate synthase (TS), and topoisomerase 2α (Topo2α) expression levels are predictive of...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Chiappori, Alberto A., Zheng, Zhong, Chen, Tingan, Rawal, Bhupendra, Schell, Michael J., Mullaney, Brian P., Bepler, Gerold
Format: Artigo
Idioma:Inglês
Publicat: 2010
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2861290/
https://ncbi.nlm.nih.gov/pubmed/20107425
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JTO.0b013e3181ccb27b
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars